Clinical significance of homocysteine and high sensitive C reactive protein in patients with acute myocardial infarction
LIU Fu-xiang1 CHEN Zhu-you2
1.Department of Internal Medicine-Cardiovascular，People′s Hospital of Yangchun City in Guangdong Province，Yangchun 529600，China；
2.Clinical Laboratory，People′s Hospital of Yangchun City in Guangdong Province，Yangchun 529600，China
Abstract：Objective To explore the clinical significance of homocysteine and high sensitive C reactive protein in patients with acute myocardial infarction.Methods 94 patients with acute myocardial infarction that diagnosed in our internal medicine-cardiovascular department from September 2015 to January 2016 of were collected as study object（research group）.94 healthy adults at the same time were selected as control group.Patients in the research group were given PCI treatment.The levels of homocysteine and high sensitive C reactive protein were detected by enzyme linked immunosorbent assay and scatter immunoassay.The levels of homocysteine and high sensitive C reactive protein were compared before and after treatment in the research group.Results The level of homocysteine and C reactive protein in research group was respectively（53.86±10.60）μmol/L and （47.52±27.38）ng/ml，higher than （8.53±4.75）μmol/L and （2.41±1.93）ng/ml in control group respectively，with statistical difference（P＜0.05）.After treatment，the level of homocysteine and high sensitive C reactive protein in the research group were （10.38+5.45）mol/L，（7.15+3.14）ng/ml，lower than that of before treatment，the difference was statistically significant（P＜0.05）.Conclusion In patients with acute myocardial infarction，the same type of homocysteine and high sensitive C reactive protein in different degrees of rise，clinically can be detected by measuring the content of these two substances indirectly suggest that patients with myocardial infarction.
刘富湘;陈注有. 急性心肌梗死患者同型半胱氨酸、超敏C反应蛋白检测的临床意义[J]. 中国当代医药, 2016, 23(19): 44-46.
LIU Fu-xiang;CHEN Zhu-you. Clinical significance of homocysteine and high sensitive C reactive protein in patients with acute myocardial infarction. 中国当代医药, 2016, 23(19): 44-46.
Zhou H，He XY，Zhuang SW，et al.Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention［J］. World J Emerg Med，2014，5（2）：96-102.
［7］
Sardella G，Stio RE.Thrombus aspiration in acute myocardial infarction：rationale and indication［J］.World J Cardiol，2014，6（9）：924-928.
Qian G，Liu HB，Wang JW，et al.Risk of cardiac rupture after acute myocardial infarction is related to a risk of hemorrhage［J］.J Zhejiang Univ Sci B，2013，14（8）：736-742.
京公网安备 11010502046607号